Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean G Rudd

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|July 15, 2023
Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunitiesSean G Rudd
Molecular Oncology|May 18, 2022
Targeting the DNA damage response and repair in cancer through nucleotide metabolismThomas Helleday, Sean G Rudd
Leukemia|February 17, 2025
Nelarabine in T-cell acute lymphoblastic leukemia: intracellular metabolism and molecular mode-of-actionFemke M Hormann, Sean G Rudd
Journal of Visualized Experiments : Jove|May 3, 2021
A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1Miriam Yagüe-Capilla, Sean G Rudd
Disease Models & Mechanisms|August 29, 2024
Understanding the interplay between dNTP metabolism and genome stability in cancerMiriam Yagüe-Capilla, Sean G Rudd
Molecular & Cellular Oncology|April 13, 2017
SAMHD1 is a barrier to antimetabolite-based cancer therapiesSean G Rudd, Torsten Schaller, Nikolas Herold
BMC Research Notes|January 20, 2021
Drug synergy scoring using minimal dose response matricesPetri Mäkelä, Si Min Zhang, Sean G Rudd
Molecular & Cellular Oncology|June 17, 2016
PrimPol-A new polymerase on the blockSean G Rudd, Julie Bianchi, Aidan J Doherty
DNA Repair|June 18, 2016
Pathways controlling dNTP pools to maintain genome stabilitySean G Rudd, Nicholas C K Valerie, Thomas Helleday
Cancers|July 26, 2018
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and MetabolismNikolaos Tsesmetzis, Cynthia B J Paulin, Sean G Rudd, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|July 15, 2023
Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunitiesSean G Rudd
Molecular Oncology|May 18, 2022
Targeting the DNA damage response and repair in cancer through nucleotide metabolismThomas Helleday, Sean G Rudd
Leukemia|February 17, 2025
Nelarabine in T-cell acute lymphoblastic leukemia: intracellular metabolism and molecular mode-of-actionFemke M Hormann, Sean G Rudd
Journal of Visualized Experiments : Jove|May 3, 2021
A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1Miriam Yagüe-Capilla, Sean G Rudd
Disease Models & Mechanisms|August 29, 2024
Understanding the interplay between dNTP metabolism and genome stability in cancerMiriam Yagüe-Capilla, Sean G Rudd
Molecular & Cellular Oncology|April 13, 2017
SAMHD1 is a barrier to antimetabolite-based cancer therapiesSean G Rudd, Torsten Schaller, Nikolas Herold
BMC Research Notes|January 20, 2021
Drug synergy scoring using minimal dose response matricesPetri Mäkelä, Si Min Zhang, Sean G Rudd
Molecular & Cellular Oncology|June 17, 2016
PrimPol-A new polymerase on the blockSean G Rudd, Julie Bianchi, Aidan J Doherty
DNA Repair|June 18, 2016
Pathways controlling dNTP pools to maintain genome stabilitySean G Rudd, Nicholas C K Valerie, Thomas Helleday
Cancers|July 26, 2018
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and MetabolismNikolaos Tsesmetzis, Cynthia B J Paulin, Sean G Rudd, et al.
Pageof 4